NTRK1 and glioma: AXL is another receptor tyrosine kinase known to be involved in ovarian cancers; AXL promoted proliferation in glioma cells and breast cancer cells [39,40], and AXL upregulation and activation was detected in ovarian cancers over normal ovaries (Figure 1 and 2) [22].